Status:
SUSPENDED
Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
JeniVision, Inc.
Conditions:
Ocular Hypertension
Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.
Detailed Description
This is an open-label, dose escalation and dose expansion, study in adult participants with open-angle glaucoma or ocular hypertension. The study is divided into 2 parts: Part 1 of the study is a dos...
Eligibility Criteria
Inclusion
- bilateral open-angle glaucoma or ocular hypertension
Exclusion
- \-
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04761705
Start Date
March 10 2021
End Date
July 1 2025
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Research Foundation
Newport Beach, California, United States, 92663